Researchers at the University of Colorado’s Anschutz Medical Campus have pioneered a groundbreaking solution to correct infant congenital heart defects (CHD) by developing a biodegradable patch engineered from the patient’s own cells. This innovative approach aims to minimize the need for multiple invasive surgeries, providing a more sustainable alternative to the current non-living, non-degradable patches.
Globally, approximately nine in every 1,000 babies born are affected by congenital heart defects, a group of conditions present at birth due to improper heart development during pregnancy. While some simple defects may not require treatment, complex defects often necessitate invasive surgeries performed over several years, typically beginning in the first year of life. The implantation of a heart patch is a common procedure during these surgeries, but existing patches, made from non-living, non-degradable materials, face limitations such as failure to integrate with heart tissue and an inability to grow with the patient’s heart.
Continue reading… “Revolutionary Biodegradable Heart Patch Offers Hope for Infant Congenital Heart Defects”